Search the Newsreel

AppLovin (APP) Is Down 9.0% After Mixed Q2 Beat-Miss And Cautious AI Ad Outlook - Has The Bull Case Changed?

AppLovin’s Real Problem Isn’t Revenue – It’s How the Growth Engine Actually Works

On August 5, 2026, AppLovin Corporation (NASDAQ:APP) announced its second-quarter results, highlighting revenue that grew by 53% to $1.92 billion. The adjusted EBITDA rose 58% to $1.61 billion at an 84% margin, while the net income reached $1.27 billion. AppLovin also confirmed that the …

AppLovin (NASDAQ:APP): A Case Study in Affordable Growth

Clover Health Investments: Real Turnaround, But Already Priced In (NASDAQ:CLOV)

Is Clover Health Investments (CLOV) Fairly Valued After A 228% Run?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Clover Health Investments has delivered a very strong 227.7% return over the past 3 years, yet the share price around US$4.49 now lines up …

AppLovin vs. SoundHound AI: Comparing Recent Revenue Growth Trajectories for These Tech Companies

Key Points AppLovin currently demonstrates a visibly stronger revenue profile, consistently maintaining a massive financial footprint and larger baseline of total recognized sales when compared against SoundHound's smaller commercial operations. Over the course of the last eight quarters, the two companies largely experienced consistently …

Clover Health Is Proving Its Profit Model (NASDAQ:CLOV)

Does Clover’s Profit Turn and Raised 2026 Guidance Reshape the Bull Case for CLOV?

Clover Health Investments, Corp. has already reported its second-quarter 2026 results, posting revenue of US$743.17 million versus US$477.62 million a year earlier and moving from a net loss of US$10.58 million to net income of US$28 million. Alongside this shift to profitability, the company …

The 5 Most Interesting Analyst Questions From Clover Health’s Q2 Earnings Call

The 5 Most Interesting Analyst Questions From Clover Health's Q2 Earnings Call Clover Health's second quarter results were met with a positive market reaction, driven by strong Medicare Advantage membership growth and improved profitability. Management credited the quarter's performance to the expansion of its …

Jim Cramer Wonders Whether AppLovin Corporation (NASDAQ:APP) Is Facing Off With Google

AppLovin Corporation (NASDAQ:APP) is a software company that operates in the digital advertising space. Its shares are down by 27% over the past year and by 49% year-to-date. AppLovin Corporation (NASDAQ:APP) has been one of the more interesting firms in today's AI-driven era due …

The Lovesac Company (NASDAQ:LOVE) Receives Average Recommendation of "Moderate Buy" from Analysts

The Lovesac Company (NASDAQ:LOVE) has received an average recommendation of "Moderate Buy" from analysts, with four out of five rating it a buy and one a sell. The average 12-month price target is $22.67, exceeding the current share price of $17.65. Despite a slight …

Lovable Lingerie standalone net profit declines 1.69% in the June 2026 quarter

Clover Health Interim CFO Joseph Clay Thornton Awarded 54,347 RSUs with Four-Year Vesting

Clover Health's Interim CFO, Joseph Clay Thornton, was granted 54,347 Restricted Stock Units (RSUs) of Class A Common Stock. These RSUs, valued at $0, will vest over a four-year period, with 25% vesting on August 12, 2027, and the remainder in quarterly installments, fully …

AppLovin’s Q2 Earnings Call: Our Top 5 Analyst Questions

AppLovin's Q2 Earnings Call: Our Top 5 Analyst Questions AppLovin's second quarter results were met with a significant negative market reaction as revenue and adjusted EBITDA both came in just below Wall Street expectations. Management attributed the shortfall to a slower pace of model …

Las acciones de AppLovin (APP) parecen estar por debajo de su valor razonable según los resultados, pero la valoración general es mixta

AppLovin (APP) Stock Looks Below Fair Value On Earnings But Mixed On Broader Checks

Applovin Corp Stock (APP) Moved Up by 3.05% on Aug 13: Key Drivers Unveiled

AppLovin at 52-Week Low: Buy, Sell or Hold?

Quick Read APP crashed 53% year-to-date to $310.95, yet Q2 delivered 53% revenue growth and 84% EBITDA margins with management blaming timing for the miss. SPY held flat since APP's Q2 filing as APP dropped 24% in one week, now sitting 44% below Wall …

AppLovin's Q2 Challenges Tied to Model Improvement Timing, RBC Says

AppLovin's (APP) Q2 challenges were largely related to the timing of a major "model improvement" rat PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already …

Clover Biopharmaceuticals Sets Board Meeting to Approve Interim Results and Consider Dividend

Broker shifts rating on Lovisa stock

Clover Health (CLOV) Q2 2026 Earnings Call Transcript

AppLovin Q3 Guidance Signals Reacceleration After a Mixed Q2 Print

AppLovin Corporation APP paired a modest second-quarter revenue miss with third-quarter guidance that points to faster sequential expansion. Revenues still increased sharply year over year, but the sequential pace slowed from the first quarter. The next test is whether that guidance translates into renewed …

Is AppLovin Stock Worth Holding as Growth Clashes With Valuation Risk?

AppLovin Corporation APP is pairing rapid earnings expansion with unusually high profitability, but the investment case is not one-sided. The stock's growth profile remains powerful while diversification, disclosure and execution risks leave less room for disappointment. For investors deciding whether to hold, add or …

AppLovin Stock Falls 6% Following Bank of America Downgrade Over Revenue Growth Risks

APP Stock Alert: AppLovin's Latest Downgrade Sends Clear Signal on Growth Trajectory

AppLovin Is Down Over 50% in 2026: Falling Knife or Fire Sale?

Quick Read AppLovin has crashed 52% in 2026 yet Wall Street's $559 consensus target implies 75% upside from current levels near the stock's 52-week low. Despite the headline Q2 miss, AppLovin grew revenue 53% year-over-year with 84% EBITDA margins and generated $863 million in …

LOVABLE Share Price Today - Lovable Lingerie Stock Analysis

AppLovin's Growth Target Just Got Harder to Defend

This article first appeared on GuruFocus. Advertising technology business AppLovin Corp. (APP, Financials) slid around 2% in premarket trade after Bank of America downgraded the stock and questioned whether its long-term growth expectations are getting too lofty.But analyst Omar Dessouky said the risks around …

AppLovin Vs. Unity: Buy The Former, The Market Got It Wrong On Earnings (NASDAQ:APP)

Micron, SpaceX, Rocket Lab, Fermi, AppLovin, and More Stocks That Explain Today’s Market

The latest consumer price index numbers come out Wednesday. Micron Technology dropped 0.8% to $854.05. The stock has declined 12% over the past month and well short of its peak of more than $1,200 reached in late June on concerns about the sustainability of …

AppLovin Stock Is Today’s Worst Performer In the S&P 500. This Is Why.

AppLovin stock took it on the chin Tuesday after a downgrade by a BofA Securities analyst who isn’t sure whether the ad-technology platform can jump-start its revenue growth. Shares were down 5% to $322.11 and were on pace for their lowest close since May …

Clover Health Eyes 2026 GAAP Profit as AI Platform Fuels Medicare Advantage Growth

Key Points Interested in Clover Health Investments, Corp.? Here are five stocks we like better. Clover Health is targeting its first full year of GAAP profitability in 2026, alongside approximately 50% membership growth, after reporting sustained adjusted EBITDA profitability and improved operating leverage. The …